Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nasdaq Says Trading Will Remain Halted Until Statera Biopharma Has Fully Satisfied Nasdaq's Request For Additional Information

Author: Benzinga Newsdesk | August 25, 2022 11:53am

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading was halted today in Statera Biopharma, Inc. (NASDAQ:STAB) at 11:01:52 A.M. Eastern Time for "additional information requested" from the company at a last sale price of $0.215.
 

Trading will remain halted until Statera Biopharma, Inc. has fully satisfied Nasdaq's request for additional information.

For news and additional information about the company, please contact the company directly or check under the company's symbol using InfoQuotesSM on the Nasdaq® Web site.

Posted In: NDAQ STAB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist